Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Papillomavirus Infections × adacel × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Human Papillomavirus-Related Cervical Carcinoma 1 Advanced Fallopian Tube Carcinoma 1

Interventions

Specimen Handling 7 Human Papillomavirus Recombinant Vaccine nonavalent 6 Colposcopy 5 Radiotherapy, Intensity-Modulated 4 Human Papillomavirus DNA Tests 4 Early Intervention, Educational 4 Cisplatin 4 artesunic acid 3 artemisinin 3 Papillomavirus Vaccines 3 Methods 3 human papillomavirus vaccine, L1 type 16, 18 2 artenimol 2 Surveys and Questionnaires 2 Patient Navigation 2 Mass Screening 2 Educational Status 2 Docetaxel 2 Carboplatin 2 Blood Specimen Collection 2 Biopsy 2 toripalimab 1 fludarabine phosphate 1 fludarabine 1 epigallocatechin gallate 1 aldesleukin 1 adacel 1 Watchful Waiting 1 Vitamin B 12 1 Triage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03180034 2025-09-04

ESCUDDO

National Cancer Institute (NCI)

Phase 4 Active not recruiting

27,945 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡